View Single Post
Old 03-09-2009, 01:14 AM   #1
donalddonald
Senior Member
 
Join Date: Mar 2009
Posts: 36
anyone on this ?-New Peptide-Based Vaccine Trial opened with the Tumor Vaccine Group

Anyone have enrolled this trial? or the first one?
could give me some opinion or information about their HER-2/neu (HER2) intracellular domain (ICD) peptide-based vaccine ?
Anyone tried this ?
thank you !



The Tumor Vaccine Group at the University of Washington is a multidisciplinary group of investigators focused on the diagnosis, prevention and treatment of cancer with novel, immune-based therapies. Involving scientists, doctors, nurses, and patients, our translational research works to bring the most innovative treatments from the bench to the bedside and to harmonize scientific study with patient care.

We invite you to explore the work we are doing, through scientific research and clinical trials, to further cancer’s diagnosis, treatment, and prevention. This site provides an introduction to immune therapies and our ongoing clinical trials program and pre-clinical research projects.
http://depts.washington.edu/tumorvac/trials.php
donalddonald is offline   Reply With Quote